Cost-effectiveness of the MitraClip device in German heart failure patients with secondary mitral regurgitation

[1] Ziaeian B(2016)Epidemiology and aetiology of heart failure Nat Rev Cardiol 13 368-378

[2] Fonarow GC(2018)New York Heart Association (NYHA) classification in adults with congenital heart disease: relation to objective measures of exercise and outcome Eur Heart J Qual Care Clin Outcomes 4 51-58

[3] Bredy C(2018)Cost-of-illness studies in heart failure: a systematic review 2004–2016 BMC Cardiovasc Disord 18 74-145

[4] Ministeri M(2018)Systematic review of economic burden of heart failure Heart Fail Rev 23 131-1248

[5] Kempny A(2015)Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations J Am Coll Cardiol 65 1231-2318

[6] Alonso-Gonzalez R(2018)Transcatheter mitral-valve repair in patients with heart failure N Engl J Med 379 2307-1891

[7] Swan L(2019)Cost-effectiveness of transcatheter mitral valve repair versus medical therapy in patients with heart failure and secondary mitral regurgitation: results from the COAPT trial Circulation 140 1881-30

[8] Uebing A(2012)Resource use and costs in systolic heart failure according to disease severity: a pooled analysis from the German Competence Network Heart Failure J Public Health 20 23-138

[9] Diller G-P(2010)A network against failing hearts–introducing the German “Competence Network Heart Failure” Int J Cardiol 145 135-51

[10] Gatzoulis MA(2007)The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator Eur Heart J 28 42-336

[1] Ziaeian B(2016)Epidemiology and aetiology of heart failure Nat Rev Cardiol 13 368-378

[2] Fonarow GC(2018)New York Heart Association (NYHA) classification in adults with congenital heart disease: relation to objective measures of exercise and outcome Eur Heart J Qual Care Clin Outcomes 4 51-58

[3] Bredy C(2018)Cost-of-illness studies in heart failure: a systematic review 2004–2016 BMC Cardiovasc Disord 18 74-145

[4] Ministeri M(2018)Systematic review of economic burden of heart failure Heart Fail Rev 23 131-1248

[5] Kempny A(2015)Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations J Am Coll Cardiol 65 1231-2318

[6] Alonso-Gonzalez R(2018)Transcatheter mitral-valve repair in patients with heart failure N Engl J Med 379 2307-1891

[7] Swan L(2019)Cost-effectiveness of transcatheter mitral valve repair versus medical therapy in patients with heart failure and secondary mitral regurgitation: results from the COAPT trial Circulation 140 1881-30

[8] Uebing A(2012)Resource use and costs in systolic heart failure according to disease severity: a pooled analysis from the German Competence Network Heart Failure J Public Health 20 23-138

[9] Diller G-P(2010)A network against failing hearts–introducing the German “Competence Network Heart Failure” Int J Cardiol 145 135-51

[10] Gatzoulis MA(2007)The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator Eur Heart J 28 42-336